Where Pacific Biosciences Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 6 analysts have published their opinion on Pacific Biosciences (NASDAQ:PACB) stock, with an average 12-month price target of $14.67. The average price target has increased by 14.61% over the past month.
June 05, 2023 | 9:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pacific Biosciences (NASDAQ:PACB) has an average 12-month price target of $14.67, according to 6 analysts. The average price target has increased by 14.61% over the past month.
The average 12-month price target for Pacific Biosciences has increased by 14.61% over the past month, indicating a positive sentiment among analysts. This could lead to a short-term increase in the stock price as investors may see this as a sign of potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100